U.S. Markets closed

IM Cannabis Corp. (IMCC.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
1.38000.0000 (0.00%)
At close: 03:35PM EDT

IM Cannabis Corp.

Kibbutz Glil Yam
Central District
Tel Aviv
972 5 44331111

IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees283

Key Executives

NameTitlePayExercisedYear Born
Mr. Marc Lustig M.B.A., M.Sc.Exec. Chairman590kN/A1974
Mr. Oren ShusterCEO & Director539.07kN/AN/A
Mr. Shai ShemeshChief Financial Officer324.96kN/AN/A
Mr. Richard BallaCEO & Director of German Operations – Adjupharm GmbH410.6kN/AN/A
Advocate Yael HarroshChief Legal & Operations OfficerN/AN/AN/A
Mr. Michael RuscettaCo-Head of North America & CEO of Trichome Financial Corp.N/AN/A1970
Mr. Howard Steinberg C.F.A.Co-Head of North America & CEO of TJACN/AN/A1966
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.


IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.

Corporate Governance

IM Cannabis Corp.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.